Tier 3 · Filer Universe
enGene Therapeutics Inc.
ENGN · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$1.78
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001980845
Liquidity rank
#4618
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | Not published | Not published | No matching frame |
| Annual diluted EPS | 2.29 | 2025-10-31 | 0001193125-25-328743 |
| Quarterly revenue | Not published | Not published | No matching frame |
| Quarterly diluted EPS | -0.43 | 2026-04-30 | 0001193125-26-270386 |
SEC EDGAR Frames batch generated 2026-08-23T22:53:06.938Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerISRG · Tier 1 peerHCA · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames